JPRN-UMIN000002802已完成未知
comparison of rosuvastatin alone versus ezetimib plus standard statin on lipid-lowering effects in patients with dyslipidemia - comparison of rosuvastatin versus ezetimib/standard statin in patients with dyslipidemia
Department of Medicine II, Hokkaido University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2009年11月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who has been treated by any strong statins (rosvastatin, atrovastatin, and pitavastatin) or ezetimib. 2. Patients who are suffered from severe liver, kidney, or heart diseases. 3. Patients who are pregnant, lactating, or could be pregnant 4. Patients with the history of allergy for study drugs. 5. Patients treated with cyclosporin. 6. Patients were deemed inappropriate for this study as the doctor.
研究者
相似试验
已完成
不适用
Ezetimibe 10 mg + rosuvastatin 2.5 mg versus rosuvastatin 5 mg for hypercholesterolemia in patients with type 2 diabetesHypercholesterolemic patients with type 2 diabetes.JPRN-UMIN000011005First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health80
已完成
4 期
Efficacy of Ezetimibe vs Rosuvastatin In Impaired Glucose Tolerance Hypercholesterolemia to TreatHypercholesterolemiaJPRN-UMIN000008049Jikei University School of Medicine,Kashiwa Hospital150
招募中
不适用
The effect of usual dose rosuvastatin plus ezetimibe versus high-dose rosuvastatin on coronary atherosclerotic plaqueDiseases of the circulatory systemKCT0003092Samsung Medical Center280
尚未招募
Unknown
A randomized comparaTive study Of rosuvastatin/ezetimibe 20/10mg and atorvastatin/ezetimibe 40/10mg in patients with coronary artery drug eLuting stEnt implantation Requiring high-dose stAtin/ezetimibe combiNaTion therapy: TOLERANT TrialKCT0008362Yonsei University Yongin Severance Hospital200
已完成
不适用
Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in OutpatientsDyslipidemiaNCT01164397AstraZeneca268